Alphatec Holdings Inc. (ATEC) Next Earnings Date & Expected ±11.4% Move

$7.04 -38.08% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $6.54

Alphatec Holdings Inc. (ATEC) carries a Roarable Rating of D (Sell) with 46/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE D • SELL / AVOID Cap $1.76B
📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on ATEC Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is ATEC stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼

As of 2026-11-02, Alphatec Holdings Inc. (NASDAQ: ATEC) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 46/100 at a spot price of $7.04 (-38.08% 1D, market cap $1.76B). Pillar breakdown: Fundamental Cash Engine 12/20, Institutional 13F & Options Flow 13/20, Executive Insider Alignment 9/20, FRED Macro Regime Fit 7/20, and SEC Balance-Sheet Forensics 5/20. Across 1016 tracked Health Care issuers, ATEC ranks #372 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does ATEC compare to KMTS and XRAY in the Health Care sector?
▼

Within the Health Care sector (Medical/Dental Instruments), ATEC carries a Roarable D (46/100 RQD), trailing P/E of N/A, gross margin of 69.6%, and ROIC of -18.4%. By comparison, KMTS (Kestra Medical Technologies Ltd.) holds a D grade (50/100 RQD, P/E N/A, ROIC -35.0%, cap $1.82B) and XRAY (DENTSPLY SIRONA Inc.) posts a E grade (32/100 RQD, P/E N/A, ROIC -11.0%, cap $1.92B). Among the 5-stock peer group, LMAT leads on earnings multiple (33.8x) while LMAT leads on capital efficiency (14.7% ROIC).

✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for ATEC?
▼

Per ATEC's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001350653), Alphatec Holdings Inc. generated $764.2M in revenue (+25.0% YoY), -$143.4M in net income, and $2.8M in free cash flow against $791.2M in total assets and $501.4M in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
🛡️ Portfolio Crash X-Ray
EXT / AFTER-HRS: $6.54 (-7.04%)🧬 Dilution Drag (+1.92% YoY Shares)⚙️ Cash Engine: 12/20 (C-) • 0.4% FCF Margin
Verify 90D Bucket Audit →
📊 Historical Track Record Warning: Scores below 50 (46/100 · D) historically underperformed SPY in 71% of rolling 90-day windows (-6.1% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →
RQD QUANT TACHOMETERSELL / AVOID • D
025507510046
2-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D · Rk D-
Cash (12)Whales (13)SEC (9)Macro (7)CEO (5)
Each axis scored 0–20
12M PRICE TARGET CONE-5.4% Base Target
$24 Bull$7 Base$5 Bear
📬 FREE ATEC RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for ATEC)Realized 20D OHLCV Swing Band: ±11.4%
Deterministic 5-Pillar Attribution (46/100 Composite)
🔍 WHY ATEC SCORES 46/100 (D) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: Whale & Options Positioning+13/20 pts (28% of score)

20D Institutional Volume Accumulation (±11.4% realized swing band)

▲ #2 Bullish Driver: Cash Engine Quality+12/20 pts (26% of score)

SEC XBRL FY 2025 (10-K): 0.4% FCF Margin ($2.8M FCF) & 69.6% Gross Margin

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution5/20 pts (-15 pt drag)

Dilution Drag (+1.92% YoY Shares) & executive Form 4 sales trim 15 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)
54
Grade C-$11.25-7.5% Next Q
Q2 (-2Q)
51
Grade C-$10.41+4.7% Next Q
Q3 (-1Q)
49
Grade D$10.90-35.4% Next Q
Current
46
Grade D$7.04-6.1% Hist 90D α
Trajectory: C- (54) → D (46)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a ATEC Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While ATEC currently carries a cautious 46/100 (D) rating due to Insider Conviction & Share Dilution (5/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Health Care with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($10.18) and Max Pain ($7.39) forces dealer call-delta covering toward $24.45.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Dilution Drag (+1.92% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $ATEC• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “ATEC Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
NEXT EST. WINDOW: Dec 30, 2026 (~57 DAYS)

Historical OHLCV Volatility ±11.4% Swing Band

±$0.80 Expected Swing
$6.24 (-11.4%)Spot $7.04$7.84 (+11.4%)
MODEL EARNINGS SETUP GAUGE

ATEC Quantitative Pre-Earnings Setup: 46/100

Trailing EPS: $4.25 • YoY Revenue Growth: 12.4%

Model Bullish Setup (46/100)Model Risk Weight (54/100)
Derived deterministically from RQD cash-flow quality, SEC accrual safety, and institutional flow (not a community poll).
LOG YOUR PERSONAL PRE-EARNINGS STANCE (SAVED LOCALLY IN BROWSER):

Recent SEC Reported Revenue, Net Profit & Diluted EPS Cadence

PeriodFiledRevenueNet ProfitFree Cash FlowGross Margin
FY 20252025-12-31$764.2M-$143.4M$2.8M69.6%
FY 20242024-12-31$611.6M-$162.1M-$127.9M69.4%
FY 20232023-12-31$0-$186.6M-$78.5M69.6%
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring ATEC)

  • ✓Walkthrough of ATEC's RQD Radar, SEC cash-conversion gap & downside invalidation levels
  • ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
  • ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
ATEC // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -31.85%▼ SUPPORT BREAKDOWN
2026-11-02O $11.45H $11.45L $7.04C $7.04VOL 7.22M
RES: $12.26SUP: $9.22SMA50: $10.18SMA200: $10.53
$15.99$13.50$11.01$8.53$6.04RES $12.26SUP $9.22$7.042026-05-042026-06-172026-08-042026-09-172026-11-02
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

ATEC Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)
8.0%/yr Implied 5Y Growth

vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on ATEC today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for ATEC. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for ATEC today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (ATEC)

Health Care Rank #372 of 1016 ⚔️ KMTS vs ATEC Full Matrix →

1. Head-to-Head Health Care Peer Comparison (ATEC vs. KMTS, XRAY, LMAT, NVCR)

Industry: Medical/Dental Instruments (120 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, Alphatec Holdings Inc. (ATEC) ranks #372 by composite RQD confidence (46/100, grade D) and #280 by equity capitalization ($1.76B). Within this direct 5-issuer industry benchmark cohort, LMAT leads on earnings valuation at 33.8x trailing P/E, while LMAT leads on capital efficiency and profitability with 14.7% ROIC and 71.5% gross margin. LMAT currently holds the highest overall quantitative score in the immediate peer group at 69/100 (C+) compared with ATEC at 46/100 (D).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
ATEC ACTIVE
Alphatec Holdings Inc.
D 46/100 — 69.6% -18.4% -38.08% $1.76B Benchmark Subject
KMTS
Kestra Medical Technologies Ltd.
D 50/100 — 51.4% -35.0% -3.01% $1.82B /kmts-vs-atec →
XRAY
DENTSPLY SIRONA Inc.
E 32/100 — 50.0% -11.0% -0.83% $1.92B /xray-vs-atec →
LMAT
LeMaitre Vascular Inc.
C+ 69/100 33.8x 71.5% 14.7% -5.08% $1.95B /lmat-vs-atec →
NVCR
NovoCure Limited
E 21/100 — 74.5% -27.5% +0.31% $1.53B /nvcr-vs-atec →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001350653

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Alphatec Holdings Inc. (ATEC) reported GAAP revenue of $764.2M (+25.0% vs. FY2024 revenue of $611.6M ) , GAAP net income of -$143.4M, operating cash flow of $45.2M, and free cash flow of $2.8M (+102.2% YoY). On the balance sheet, ATEC closed FY2025 with $791.2M in total assets against $501.4M in total debt (Altman Z-Score: N/A, Piotroski F-Score: 6/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2025-12-31 $764.2M -$143.4M $45.2M $2.8M $791.2M $501.4M
FY2024 (FY) 2024-12-31 $611.6M -$162.1M -$44.7M -$127.9M $775.7M $574.5M
FY2023 (FY) 2023-12-31 $0 -$186.6M -$78.5M -$78.5M — —

3. ATEC Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is ATEC stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-02, Alphatec Holdings Inc. (NASDAQ: ATEC) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 46/100 at a spot price of $7.04 (-38.08% 1D, market cap $1.76B). Pillar breakdown: Fundamental Cash Engine 12/20, Institutional 13F & Options Flow 13/20, Executive Insider Alignment 9/20, FRED Macro Regime Fit 7/20, and SEC Balance-Sheet Forensics 5/20. Across 1016 tracked Health Care issuers, ATEC ranks #372 in composite RQD confidence.

How does ATEC compare to KMTS and XRAY in the Health Care sector?

Within the Health Care sector (Medical/Dental Instruments), ATEC carries a Roarable D (46/100 RQD), trailing P/E of N/A, gross margin of 69.6%, and ROIC of -18.4%. By comparison, KMTS (Kestra Medical Technologies Ltd.) holds a D grade (50/100 RQD, P/E N/A, ROIC -35.0%, cap $1.82B) and XRAY (DENTSPLY SIRONA Inc.) posts a E grade (32/100 RQD, P/E N/A, ROIC -11.0%, cap $1.92B). Among the 5-stock peer group, LMAT leads on earnings multiple (33.8x) while LMAT leads on capital efficiency (14.7% ROIC).

What are the biggest fundamental strengths and SEC risk factors for ATEC?

Per ATEC's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001350653), Alphatec Holdings Inc. generated $764.2M in revenue (+25.0% YoY), -$143.4M in net income, and $2.8M in free cash flow against $791.2M in total assets and $501.4M in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is ATEC trading relative to its 50-day, 200-day, and 52-week technical levels?

ATEC last traded at $7.04 (-38.08% on volume of 27,299,430 shares), positioning the stock -30.84% below its 50-day simple moving average ($10.18) and -33.14% below its 200-day simple moving average ($10.53). Across its 52-week range of $6.81 to $23.29, ATEC sits at the 1.4% percentile with a 14-day RSI of 54.1 (NEUTRAL RANGE) and an implied next-earnings move of ±11.4% ($6.24 to $7.84).

ATEC Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

When is ATEC's next earnings date?

Based on SEC filing cadence, Alphatec Holdings Inc. (ATEC)'s next quarterly reporting window is estimated around Dec 30, 2026.

How much is ATEC stock expected to move on earnings?

Volatility modeling currently projects a ±11.4% event move for ATEC, spanning a range between $6.24 and $7.84.

ROARABLE RATING BRIEF • RQD 46/100 (D) ✓ STAGE-C NUMBER FIREWALL VERIFIED

ATEC — Alphatec Holdings Inc.: What the Facts Mean to a Prospective Investor

Engine: anthropic/claude-haiku-5.5
As of: 2026-11-02T15:27:53Z

Roarable Rating Brief: What This Means to a Prospective Investor

The Roarable RQD rating is 46 out of 100, a letter grade of D, with the verdict "Roarable Sell — Underperform / Distribution Warning" (per the Roarable RQD rating). The five pillars score as follows:

  • Fundamental Cash Engine: 12 / 20. The rating cites ROIC of -18.4% and an FCF yield of 0.16%. For a prospective investor, this indicates the business is not currently generating meaningful returns on invested capital, and the cash yield offers little valuation support at the current price.
  • Whale 13F Flow: 13 / 20. The rating describes institutional accumulation and options positioning. This is the strongest pillar, suggesting some institutional interest, though the source data does not itemize the holdings (see Analyst View section).
  • Insider Conviction: 5 / 20. The rating references SEC Form 4 and Congressional PTR cluster flow, scored low. This is the weakest pillar, indicating limited insider signal of confidence.
  • Macro Regime Fit: 7 / 20. The rating lists a beta of 1.0 and sector sensitivity as the basis. For an investor, this means the stock is expected to move in line with the broad market while carrying sector-specific exposure, without a clear macro tailwind identified in the source data.
  • Forensic Balance Sheet: 9 / 20. The rating cites an Altman Z-Score of 2.5, a Piotroski F-Score of 6/9, and Debt/Equity of 8.5. These point to a leveraged balance sheet with moderate financial-health signals, which constrains downside tolerance.

Taken together, the rating frames ATEC as a stock where operating losses, thin free cash flow, and leverage outweigh the institutional-flow signal. Upside drivers would need to come from margin recovery and improved cash conversion, which the current data does not show. The 52-week range of $6.81 - $23.29 against a price of 11.37 illustrates how wide the trading band has been, which increases volatility risk for a prospective investor. This is an educational summary of the rating's components, not personalized financial advice.

Financial Trend

PeriodRevenueOperating IncomeNet IncomeEPSFCFCashDebt
FY 2025$764.2M$-82.1M$-143.4MN/A$2.8M$160.8M$501.4M
FY 2024$611.6M$-136.2M$-162.1MN/A$-127.9M$138.8M$574.5M
FY 2023$0.0M$-173.4M$-186.6MN/A$-78.5MN/AN/A

Per the SEC financials, the company reported operating losses in all three periods, narrowing from $-173.4M (FY 2023) to $-82.1M (FY 2025) while revenue grew from $611.6M (FY 2024) to $764.2M (FY 2025). Per the market data, gross margin is 69.6%, operating margin -10.7%, and net margin -18.8%. ROIC is -18.4%. Per the Roarable RQD rating, the Altman Z-Score is 2.5 and the Piotroski F-Score is 6/9, with Debt/Equity of 8.5. Debt declined from $574.5M to $501.4M across FY 2024 to FY 2025 while cash rose to $160.8M.

Recent Catalysts & News Wire Analysis

  • Yahoo! Finance Canada (1h ago), MARKET WIRE: General market-action coverage with no specific event described.
  • TradingView (3h ago), MARKET WIRE: Titled as an estimates report; the summary contains no estimate figures.
  • Yahoo Finance (6h ago), MARKET WIRE: Headline references a potential undervaluation tied to cash flow recovery. This is a headline claim, not a verified fact in the data.
  • Moomoo (9h ago), MARKET WIRE: Options chain and quotes page.
  • Yahoo Finance (12h ago), CATALYST, GREEN: Headline references a Madison Small Cap Fund commentary on market share gains and margin expansion potential. This is the only item tagged as a catalyst and the only GREEN item.
  • Yahoo Finance (15h ago), MARKET WIRE: Headline reports Q3 earnings and revenues lagging estimates.

Risk watch: the Q3 earnings miss headline is the most material negative item in the feed. Positive framing rests on the fund commentary and the cash-flow recovery headline, neither of which is quantified in the source data. The Butterfly Supply-Chain Graph reports no supply-chain links and no proprietary signals.

Open Questions

  • What are the company's products, customers, and principal revenue sources?
  • What are the trailing and forward earnings per share and valuation multiples, given P/E, EPS, and EV/EBITDA are absent?
  • What is the composition of the debt load and its maturity profile, given debt is reported without terms?
  • What drove the FY 2024 to FY 2025 revenue increase, and is operating-loss narrowing sustainable?
  • Which institutions hold the stock, and what are the specific insider and 13F transactions behind the rating's flow pillars?

ATEC Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Alphatec Holdings Inc. (ATEC) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to ATEC Debate Forum (3) ↓
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

ATEC Bull vs. Bear Conversation Board — What's Your Call at $7.04?

🐂 50% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON ATEC 🐻 50% BEARISH CONVICTION
1. Pick Your Side on ATEC:
💡 Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
RO RoarDesk_Moderator Roarable Research Desk ⚖️ DEBATE HOST 🎯 Target: $12.28 (+8.0%)
📌 Pinned Debate

🔥 Official Bull vs. Bear Debate: Is ATEC (D • RQD 46/100) a Buy at $11.37?

Welcome to the ATEC (Alphatec Holdings Inc.) Roar Pit. Current RQD Composite is 46/100 (Roarable Sell — Underperform / Distribution Warning) in Medical/Dental Instruments. Bulls point to operating leverage and sector positioning, while bears focus on macro rate sensitivity and margin execution. Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.

SH ShortSeller_Dan Forensic Accounting Watch 🐻 BEARISH 🎯 Target: $8.75 (-23.0%)
Spot @ $11.37

Pump the brakes on ATEC — check the valuation vs. margin headwinds

Everyone in here is repeating the bull case on ATEC, but look at what you are paying: current EV/EBITDA multiples with 69.6% gross margins. Unless Alphatec Holdings Inc. expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.

MA MacroHawk_NYC Verified K Arena Trader 🐂 BULLISH 🎯 Target: $14.33 (+26.0%)
Spot @ $11.37

ATEC cash flow & RQD setup is being underpriced by the Street here

Looking at the 5-pillar RQD breakdown on ATEC, the market is fixating on short-term headline noise in Medical/Dental Instruments and ignoring the balance sheet and cash flow trajectory. At $11.37 (52-wk range $6.81 - $23.29), any beat on forward guidance forces shorts and underweight funds to chase.

LIVE TAPE SPY $755.72 -0.38% QQQ $690.49 -1.44% DIA $517.13 -0.37% IWM $279.33 +0.96% NVDA $204.64 -4.22% AAPL $344.63 -1.23% MSFT $521.91 -1.55% TSLA $399.81 -0.86% PLTR $184.11 -6.27% SOFI $16.76 -4.83% IBIT $43.36 -0.94% GLD $355.78 -1.34%